Information about Attana's presentation at Småbolagsdagarna on June 7 at 16.30
On Monday, June 7 at 16.30 Attana will participate in Aktiespararnas event, Småbolagsdagarna, where Attana’s CEO, Teodor Aastrup, will present the company and answer questions from stakeholders.
The presentation will include a brief description of the company and its two business areas, Attana Life Science and Attana Diagnostics and focus on both the short- and long-term plans going forward.
Preliminary agenda for the presentation
- Attana in short
- Attana Life Science
- Attana Diagnostics
- Going forward
The event will be open for all and no registration is required to access the event digitally. Any questions for Attana’s CEO can be sent by SMS to +46 793 47 98 45 or emailed to email@example.com. The questions will be forwarded by Aktiespararna’s own moderator after the presentation. You are welcome to send questions both before and during the presentation.
When: June 7 at 16.30
Where: Digital (www.aktiespararna.se/tv/live)
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org